Monthly Archives: August 2019

CLASS ACTION UPDATE for DBD, CTST and NFLX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 26, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Diebold Nixdorf, Incorporated (NYSE:DBD)

Lawsuit on behalf of: investors who purchased February 14, 2017 – August 1, 2018
Lead Plaintiff Deadline : September 3, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/diebold-nixdorf-incorporated-loss-form?prid=3182&wire=1

According to the filed complaint, during the class period, Diebold Nixdorf, Incorporated made materially false and/or misleading statements and/or failed to disclose that: (1) as a result of the Wincor acquisition and related integration, the Company was less focused on its core business; (2) the Company expected certain customers would not renew their service contracts (i.e. contract runoff); (3) the Company was not adequately prepared to staff service technicians; (4) as a result of the expected contract runoff, the Company would suffer a shortage of adequately trained service technicians; (5) as a result, the Company would suffer margin pressure in its services segment; (6) as a result of the foregoing, the Company would lose market share; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

CannTrust Holdings Inc. (NYSE:CTST)

Lawsuit on behalf of: investors who purchased November 14, 2018 – July 12, 2019
Lead Plaintiff Deadline : September 9, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/canntrust-holdings-inc-loss-form?prid=3182&wire=1

According to filed complaints, CannTrust Holdings Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was growing cannabis in its Pelham greenhouse while applications for regulatory approval were still pending; (2) the Company’s Pelham greenhouse did not comply with certain regulations; (3) as a result, the Company was reasonably likely to face an inventory hold by Health Canada until the Pelham facility becomes compliant with applicable regulations; (4) as a result, the Company’s customers would face shortages and would likely seek product from CannTrust’s competitors; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Netflix, Inc. (NASDAQGS:NFLX)

Lawsuit on behalf of: investors who purchased April 17, 2019 – July 17, 2019
Lead Plaintiff Deadline : September 20, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/netflix-inc-loss-form?prid=3182&wire=1

According to the filed complaint, during the class period, Netflix, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Netflix would not be able to gain its expected target number of new subscribers in the second quarter of 2019; (2) Netflix would also lose subscribers from the United States in the second quarter of 2019; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 557488

Himachal Mukhopadhyay Discusses How Artificial Intelligence Can Improve Healthcare Delivery for Everyone

ROSEVILLE, CA / ACCESSWIRE / August 26, 2019 / Healthcare professional Himachal Mukhopadhyay reviews emerging medical technology to determine its usefulness in practices around the world. Following trends in the media, he helps readers understand how artificial intelligence can be applied to healthcare and how it can expedite and strengthen the delivery of services of medical practitioners everywhere.

Himachal Mukhopadhyay has over two decades of healthcare experience to his name, and he’s witnessed the growth and implementation of a range of technologies in the medical field. He’s served as a strategic advisor on best medical practices, and he’s a big believer in improved technology for optimized healthcare delivery.

“Our scientific understanding of certain illnesses like cancer or health factors like diet is growing at an exponential rate, but so is our relationship with technology,” says Himachal Mukhopadhyay. “Newer, better tools help healthcare professionals provide total solutions with lower impact on the patient, and technology such as artificial intelligence is changing how doctor offices and hospitals interpret and organize data.”

When people hear the term artificial intelligence (AI), they tend to rely on Hollywood depictions that spell disaster for humans. Instead, AI is a highly-specialized tool that can be implemented in a range of medical applications to enhance the overall process for both patients and practitioners.

Advances in AI are proving especially useful in fields like diagnostics where new algorithms and programs can search through and return information from huge sets of data. These tasks were reserved for office staff in the past, but newer and better AI interfaces can help us categorize data faster than ever and learn from bulk sets of information. This enhances many facets such as improved medical records, faster biometric and vital processing, quicker access to genetic information and more.

The fast thinking of AI saves time across the board and allows physicians and medical professionals to spend more time with patients and less time searching for information. Because of their ability to learn, certain AI programs can offer specific treatment advice after reviewing bulk sets of data from medical records.

“Through AI, computer systems can get to know patients and return anything from their documents that may be helpful in current diagnosis or treatment,” says Himachal Mukhopadhyay. “These systems can go through countless data sets and provide speedy query results for patient information like Google.”

In addition, artificial intelligence is being used as a bedside companion to certain patients (such as in remote patient monitoring technology) where it can record vitals and make suggestions beyond reminding them to take medications. It can act as an in-home nurse and provide direct links to medical information or assistance, freeing up time for medical professionals in physical offices.

“Artificial intelligence is revolutionizing medical delivery and patient record keeping, which is helping free up doctor’s schedules to spend more time with the patients that need immediate attention,” says Himachal Mukhopadhyay. “And we’ve only scratched the surface on what this technology is capable of.”

CONTACT:

Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence

ReleaseID: 557484

SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Pluralsight, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Pluralsight, Inc. (“Pluralsight” or “the Company”) (NASDAQ:PS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between August 2, 2018 and July 31, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before October 15, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Pluralsight failed to execute on its sales strategies, which impacted its billing to customers. The Company also suffered from delays in hiring and training an effective salesforce to meet its financial projections. Pluralsight fell behind in onboarding new sales reps, which compounded the execution problems already plaguing the organization. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Pluralsight, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
Brian Schall, Esq.,
Rina Restaino, Esq.,
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557482

SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NetApp, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against NetApp, Inc. (“NetApp” or “the Company”) (NASDAQ:NTAP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between May 22, 2019 and August 1, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before October 14, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. NetApp was incapable of closing large sales, finding deals pushed to later quarters or downsized. This failure to close large deals materially impacted revenue, resulting in the Company lowering its fiscal 2020 guidance. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about NetApp, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557480

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Granite Construction Incorporated and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Granite Construction Incorporated (“Granite” or “the Company”) (NYSE:GVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between October 26, 2018 and August 1, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before October 14, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Granite took on various risks associated with bids for heavy civil joint venture projects between 2012 and 2014. The distribution of risk between the Company and the joint venture project partners was unbalanced to the point of being “untenable.” Based on the imbalance of risk, the Company was likely to incur both additional project costs and dispute costs. Based on the facts the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Granite, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557478

Can CBD Help Manage Autism? Best CBD Oil for Autism

SEATTLE, WA / ACCESSWIRE / August 26, 2019 / PopularCBDBrands: Cannabidiol, also referred to as CBD, is a safe, effective, and affordable natural remedy. CBD is extracted from cannabis and hemp plants and does not contain significant levels of THC, the psychoactive component of cannabis associated with a “high.” However, CBD has been demonstrated to lower anxiety levels and reduce stress, common symptoms of those with autism. CBD’s therapeutic applications may offer treatment of autism, and improve communication and behavior in both children and adults on the autism spectrum.

What is CBD Oil?

One important source providing clarity is PopularCBDBrands.com. Popular CBD Brands offers unbiased reviews, educational content, and covers the cutting-edge research available regarding the benefits of CBD. Recently, Popular CBD Brands put together an article titled “Can CBD Help with Autism?,” which highlights the most recent research regarding the impact of CBD on those with autism.

CBD is most commonly derived from hemp plants, the cousin of the marijuana plant whose cultivation was made legal in the 2018 Farm Bill. CBD’s popularity has grown exponentially in recent years, with a recent GALLOP poll showing 14% of Americans using CBD to alleviate symptoms of pain, sleep, anxiety, epilepsy, and more.

CBD can be purchased online and shipped to your doorstep. CBD can be purchased in many forms. The most popular form, being the CBD oil tincture. In this emerging market, claims and prices from CBD companies can vary greatly, and consumers often struggle to find quality CBD at an affordable price.

How CBD May Help with Autism

Autism is a developmental disorder which stems from a mixture of genetic and environmental factors that impacts 1 in 60 children in the US, and a total of 75 million people worldwide. Autism is a spectrum disorder, meaning that people experience a wide range of symptoms and at varying levels of severity.

While there is no treatment to cure or remove the symptoms of autism, which include repetitive behavior, difficulty understanding emotions, social communication challenges, just to name a few. CBD has been demonstrated to help address disorders associated with autism including anxiety, the ability to communicate, and epilepsy. By addressing these associated disorders, CBD offers promise in the management of the challenging behaviors common to autism.

Research Findings

A recent study to be published in the journal Neurology, researchers found that when they treated autistic children with CBD conditions improved by a stunning 80%. The study was carried out by Dr. Adi Aran, the director of pediatric neurology at Jerusalem’s Shaare Zedek Hospital. In total 60 children were treated with CBD oil over the course of 7 months. At the end of the trial, parents of the children were asked to evaluate the changes in their child’s condition in regards to behavior, anxiety levels, and communication abilities.

They reported some impressive results:

80% reported a decrease in problematic behaviors, with 62% reporting significant improvements.
50% of the participants were reported to have improved communication skills.
40% reported a significant decrease in anxiety.

The research indicates that CBD may be able to help the millions of parents of children with autism and adults with autism seeking treatment to support their journey with autism. This research emerges to support the years of anecdotal evidence shared by CBD users. One testimony found on the popular CBD forum, r/CBDOilReviews, exemplifies the many success stories shared among users:

“My daughter is 7 and has ASD. She’s ‘high-functioning,’ but we’re using CBD to work with her behavioral, sensory issues, social skills and sleeping issues. She started taking it a few weeks ago. I swear she made near immediate changes. Just a bit longer eye contact and weeks later even longer.”

While research regarding CBD and Autism is in its early stages, the future of CBD as a therapeutic option for addressing the symptoms of autism is promising.

How to Choose the Right CBD Oil
The exciting research supporting CBD and the safety associated with CBD use, make trying CBD oil as clear choice for many. However, before buying a CBD oil tincture it is important to make an informed choice in regards to the correct CBD brand. Popular CBD Brands, has reviewed hundreds of CBD products and companies in order to help the consumer make an informed decision. Their #1 recommended CBD oil tincture is from the brand BioMD+. bioMDplus’s CBD oil tinctures are derived from 100% Organic Colorado hemp, 3rd party lab-tested, and infused with natural terpenes to increase the efficacy of the CBD. BioMD+ ships to all 50 states with free shipping and a 30 day return policy. Instead of doing hours of online research, Popular CBD Brands reviews and recommends the best CBD oil brands for you. You can read their full list of top CBD companies here: https://popularcbdbrands.com/best-cbd-oils.

Contact:

Josiah Majetich
Editor, https://popularcbdbrands.com
info@popularcbdbrands.com
(440) 636-2865

https://www.leafly.com/news/health/research-cbd-autism-therapy-promising-results
https://news.gallup.com/poll/263147/americans-say-cbd-products.aspx
https://www.cdc.gov/ncbddd/autism/data.html
https://popularcbdbrands.com/can-cbd-help-with-autism/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/

SOURCE: Popular CBD Brands

ReleaseID: 557434

SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Valaris plc and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Valaris plc (“Valaris” or “the Company”) (NYSE:VAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between April 11, 2019 and July 31, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before October 21, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Valaris suffered from serious weakness in its ultra-deepwater segment, heavy cash expenditures, and negative cash flow. These negative factors were likely to impact the Company’s second quarter 2019 results. The merger that resulted in the creation of Valaris had no ability to deliver on its promises of efficiencies and improvements. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Valaris, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557479

SEPTEMBER 3 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Diebold Nixdorf, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Diebold Nixdorf, Inc. (“Diebold” or “the Company”) (NYSE:DBD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between May 4, 2017 and July 4, 2017, inclusive (the ”Class Period”), are encouraged to contact the firm before September 3, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Diebold experienced delays and slowdowns in a number of areas, including system rollouts, customer decision-making, and the order-to-revenue conversion cycle. These delays had a negative impact on the Company’s operations and its service business. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Diebold, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557476

Robert Thomson Offers a Closer Look at New Featured Listing

JUPITER, FL / ACCESSWIRE / August 26, 2019 / Waterfront Properties’ Robert Thomson provides insight into his latest incredible Frank Israel-designed listing in Jupiter, Florida.

With a bar, billiards room, clubhouse, gym, sauna, and more, Robert Thomson’s spectacular Frank Israel-designed listing on Spyglass Lane comes to the market at $7.5 million. Located in Jupiter, Florida, and boasting more than 100 feet of beautiful water frontage, Waterfront Properties and Club Communities owner Thomson reveals more about the incredible property.

“In addition to its own bar, a billiards room, clubhouse, gym, and sauna, the property also boasts a media room and access to tennis courts, a golf course, health club, park, playground, and much more,” reveals Thomson.

Directly on the waterfront, the property was designed by innovative and internationally renowned architect Frank Israel, and marks one of his final residential projects, according to Robert Thomson. “As you enter this one-of-a-kind modern marvel, you’re immediately wowed by the unique structures and craftsmanship on offer,” suggests the leading South Florida luxury real estate professional.

Featuring six bedrooms and five bathrooms, the home, he says, is a pure architectural wonder, with a large living room and dining room enjoying expansive waterfront views along with a barrier island, perfectly protecting the property’s more than 100 feet of water frontage.

“Delight in countless hours outdoors with a wide lawn, lap pool, and covered entertaining areas,” adds Thomson. “The master bedroom boasts both his and hers full baths and closets,” he goes on, “plus a sitting area with wide picture windows, enjoying the ultimate in luxury and privacy.”

Along with driveway parking, a large garage, and additional space for a golf cart and the owner or owners’ boat or boats, exterior features at the $7.5 million property on Spyglass Lane also include a barbecue, gated entry, automatic pool cleaner, and a large, open gathering space, plus built-in garden and lawn sprinklers.

Inside, luxurious marble and wooden floors, skylights, walk-in closets, floor-to-ceiling windows, and an elevator are perfectly complemented by central air conditioning, high-tech security systems, a kitchen pantry, and all of the high-end, modern conveniences which the buyer of a home of this caliber might expect, according to Waterfront Properties boss Robert Thomson.

“The property is also ideally located,” he adds, wrapping up, “for a number of excellent local elementary, middle, and high schools.”

For more information, visit Waterfront Properties and Club Communities owner and co-founder Robert Thomson’s listing on LuxuryRealEstate.com at https://www.luxuryrealestate.com/residential/3153122/.

CONTACT:

Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence

ReleaseID: 557475

Newsflare Promotes Monique Macias to Director of US Licensing

Macias To Take Lead Role in Licensing User-Generated Videos to Media Networks and Publishers Across The Americas, Based in Newsflare’s Los Angeles Offices

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / Newsflare, a global leader in licensing User-Generated Videos (UGV) for broadcast news and entertainment producers and digital media publishers worldwide, has promoted Monique Macias to Director of US Licensing from her previous position as Syndication Manager, effective immediately. In her expanded role with Newsflare, Macias will lead editorial & publisher sales, including news organizations, media networks, online & social media publishers in the Americas. Based in the company’s Los Angeles office, Macias will continue to report to Preeya Naul, General Manager, US.

Monique Macias

“Monique has served as a crucial part of our success over the last year and has made a significant contribution to our US Editorial sales effort. We look forward to continuing to develop business in the Americas, and to Monique’s ongoing success in driving this forward with the most prestigious media companies in the region as she assumes her new responsibilities as Director of US Licensing,” said Naul.

Macias joined Newsflare in May 2018 with extensive experience across traditional media, OTT and digital distribution. She previously served as Business Development Manager, Licensing for Los Angeles-based Defy Media, a respected digital producer and programmer targeting the youth and young adult markets, where she led global User Generated Content (UGC) licensing efforts and strategy. Prior to Defy Media, Macias held Business Development roles with companies NASDAQ/GlobeNewswire and online video platform Xstream. Macias also held the position of Affiliate Sales & Marketing Manager for NUVOtv, a top broadcast television network for American Latinos.

Formed in March, 2018, Newsflare’s Los Angeles office serves media companies across the America’s with a focus on editorial use on TV & online, original program development with US production partners, whilst also generating sales with brands and advertising agencies. In addition to its sales effort, Newsflare coordinates video acquisition and cultivation from Newsflare’s uploaders from across the region.

About Newsflare

Headquartered in London with offices in the US and Spain, Newsflare is the media’s pioneering leader in sourcing trusted and compelling eyewitness video. Newsflare’s 75,000-plus members upload viral video and breaking news, bought by broadcast and digital media clients that span more than 50 countries. Under the banner Where the World’s Media Come to Buy Your Video, Newsflare delivers stories from all walks of life that are often too breaking or too remote for traditional media organizations to capture. Visit www.Newsflare.com.

CONTACT:

Steve Syatt
SSA Public Relations
steve@ssapr.com
(818) 222-4000

SOURCE: Newsflare

ReleaseID: 557465